AP829A - Novel hormonal medicaments and use thereof correcting oestrogen deficiencies. - Google Patents

Novel hormonal medicaments and use thereof correcting oestrogen deficiencies. Download PDF

Info

Publication number
AP829A
AP829A APAP/P/1997/000979A AP9700979A AP829A AP 829 A AP829 A AP 829A AP 9700979 A AP9700979 A AP 9700979A AP 829 A AP829 A AP 829A
Authority
AP
ARIPO
Prior art keywords
oestrogen
group
oestradiol
oestro
placebo
Prior art date
Application number
APAP/P/1997/000979A
Other languages
English (en)
Other versions
AP9700979A0 (en
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP829(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of AP9700979A0 publication Critical patent/AP9700979A0/xx
Application granted granted Critical
Publication of AP829A publication Critical patent/AP829A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1997/000979A 1995-08-01 1996-07-29 Novel hormonal medicaments and use thereof correcting oestrogen deficiencies. AP829A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
PCT/IB1996/000754 WO1997004784A1 (fr) 1995-08-01 1996-07-29 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (2)

Publication Number Publication Date
AP9700979A0 AP9700979A0 (en) 1997-07-31
AP829A true AP829A (en) 2000-05-03

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/000979A AP829A (en) 1995-08-01 1996-07-29 Novel hormonal medicaments and use thereof correcting oestrogen deficiencies.

Country Status (31)

Country Link
US (1) US5891867A (xx)
EP (1) EP0783310B1 (xx)
JP (1) JPH10507207A (xx)
KR (1) KR100450649B1 (xx)
CN (1) CN1138547C (xx)
AP (1) AP829A (xx)
AR (1) AR004502A1 (xx)
AT (1) ATE225659T1 (xx)
AU (1) AU722355B2 (xx)
BR (1) BR9606549A (xx)
CA (1) CA2201368C (xx)
CZ (1) CZ289706B6 (xx)
DE (1) DE69624214T2 (xx)
DK (1) DK0783310T3 (xx)
DZ (1) DZ2078A1 (xx)
ES (1) ES2184880T3 (xx)
FR (1) FR2737411B1 (xx)
HK (1) HK1005227A1 (xx)
HU (1) HU229843B1 (xx)
IL (1) IL120558A (xx)
MA (1) MA23946A1 (xx)
MX (1) MX9702381A (xx)
MY (1) MY117307A (xx)
NO (1) NO312996B1 (xx)
OA (1) OA10411A (xx)
PT (1) PT783310E (xx)
RU (1) RU2188641C2 (xx)
TN (1) TNSN96101A1 (xx)
TW (1) TW473390B (xx)
WO (1) WO1997004784A1 (xx)
ZA (1) ZA966545B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
EP1390038A2 (en) * 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
WO2003049744A1 (en) 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
WO2005007112A2 (en) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229612A1 (de) * 1981-08-10 1983-02-24 Syntex (U.S.A.) Inc., 94304 Palo Alto, Calif. Pharmazeutische packung
WO1994006437A1 (fr) * 1992-09-21 1994-03-31 Laboratoire Theramex S.A. Implants sous-cutanes a base de derives de nomegestrol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229612A1 (de) * 1981-08-10 1983-02-24 Syntex (U.S.A.) Inc., 94304 Palo Alto, Calif. Pharmazeutische packung
WO1994006437A1 (fr) * 1992-09-21 1994-03-31 Laboratoire Theramex S.A. Implants sous-cutanes a base de derives de nomegestrol

Also Published As

Publication number Publication date
ES2184880T3 (es) 2003-04-16
DK0783310T3 (da) 2003-02-10
MX9702381A (es) 1998-02-28
ATE225659T1 (de) 2002-10-15
FR2737411A1 (fr) 1997-02-07
ZA966545B (en) 1997-05-08
PT783310E (pt) 2003-02-28
KR100450649B1 (ko) 2004-11-16
WO1997004784A1 (fr) 1997-02-13
CZ96797A3 (cs) 1998-08-12
NO971449D0 (no) 1997-03-26
FR2737411B1 (fr) 1997-10-17
MA23946A1 (fr) 1997-04-01
DE69624214T2 (de) 2003-07-10
AP9700979A0 (en) 1997-07-31
BR9606549A (pt) 1998-06-23
NO971449L (no) 1997-05-30
CA2201368A1 (fr) 1997-02-13
NO312996B1 (no) 2002-07-29
OA10411A (fr) 2001-12-06
HUP9900612A3 (en) 1999-11-29
AR004502A1 (es) 1998-12-16
AU722355B2 (en) 2000-07-27
EP0783310A1 (fr) 1997-07-16
HUP9900612A2 (hu) 1999-07-28
CZ289706B6 (cs) 2002-03-13
US5891867A (en) 1999-04-06
HU229843B1 (en) 2014-09-29
DE69624214D1 (de) 2002-11-14
MY117307A (en) 2004-06-30
IL120558A (en) 2002-09-12
RU2188641C2 (ru) 2002-09-10
CA2201368C (fr) 2010-12-07
DZ2078A1 (fr) 2002-10-22
IL120558A0 (en) 1997-07-13
HK1005227A1 (en) 1998-12-31
CN1167438A (zh) 1997-12-10
KR970706004A (ko) 1997-11-03
TNSN96101A1 (fr) 2005-03-15
EP0783310B1 (fr) 2002-10-09
AU6367496A (en) 1997-02-26
CN1138547C (zh) 2004-02-18
TW473390B (en) 2002-01-21
JPH10507207A (ja) 1998-07-14

Similar Documents

Publication Publication Date Title
AP829A (en) Novel hormonal medicaments and use thereof correcting oestrogen deficiencies.
US7749987B2 (en) Contraception method
KR100623788B1 (ko) 호르몬 조성물 및 이의 용도
RU2258512C2 (ru) Противозачаточное лекарственное средство на основе гестагена и эстрогена и способ его получения
JPH01211527A (ja) 更年期障害及びオステオポローシスの治療用医薬投与ユニット
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
CN101583364A (zh) 减轻子宫内膜异位的药物制剂
EP1178807B1 (en) Use of org 33245 in combined intermittent hormone therapy and contraception
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
KR20030043797A (ko) 호르몬 조성물
CN117715644A (zh) 纯孕激素口服避孕
MXPA99003291A (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound